Oxford Biomedica plc (OTCMKTS:OXBDF - Get Free Report)'s stock price fell 0.9% during trading on Monday . The company traded as low as $4.79 and last traded at $5.00. 23,862 shares were traded during trading, an increase of 206% from the average session volume of 7,795 shares. The stock had previously closed at $5.05.
Oxford Biomedica Stock Performance
The company has a quick ratio of 2.07, a current ratio of 2.35 and a debt-to-equity ratio of 1.48. The business has a fifty day moving average price of $5.21 and a 200 day moving average price of $4.99.
About Oxford Biomedica
(
Get Free Report)
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
See Also
Before you consider Oxford Biomedica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Biomedica wasn't on the list.
While Oxford Biomedica currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
